Abstract:Pseudomonas aeruginosa, a formidable pathogen renowned for its antimicrobial resistance, poses a significant threat to immunocompromised individuals. In that respect, the MexAB-OprM efflux pump plays a pivotal line of defense by extruding antimicrobials from bacterial cells. The inner membrane homotrimeric protein, MexB, captures antibiotics and translocate them into the outer membrane OprM channel protein connected through the MexA adaptor protein. Despite extensive efforts, competitive inhibitors targeting the tight (T) protomer of the MexB protein have not received FDA approval for medical use. Over the past few years, allosteric inhibitors have become popular as an alternative to the classical competitive inhibitor-based approach because of higher specificity, lower dosage, and reduced toxicological effects. Hence, in this study, we unveiled the existence of a transmembrane allosteric binding pocket of MexB inspired by the recent discovery of an important allosteric inhibitor, BDM88855, for homologs AcrB protein. While repurposing BDM88855 proved ineffective for controlling the MexB loose (L) protomer, our investigation identified a promising alternative— a chlorine-containing variant of DB08385 (2-Cl DB08385 or Variant 1). Molecular dynamics simulations, including binding free energy estimation coupled with heterogeneous dielectric implicit membrane model (implicit-membrane MM/PBSA), interaction entropy (IE) analysis and the potential of mean force (PMF) calculation demonstrated Variant 1's superior binding affinity to the transmembrane pocket, displaying the highest energy barrier in the ligand unbinding process. To elucidate the allosteric crosstalk between the transmembrane and porter domain of MexB, we employed the 'Eigenvector Centrality' measure in the linear mutual information obtained from the protein correlation network. Notably, this study confirmed the presence of an allosteric transmembrane site in MexB L protomer. In addition to that, Variant 1 emerged as a potent regulator of allosteric crosstalk, inducing an 'O – L intermediate state' in MexB L protomer. This induced state might hold the potential to diminish substrate intake into the access pocket leading to ineffective efflux of the antibiotics.

Insight through molecular mechanics Poisson-Boltzmann surface area calculations into the binding affinity of triclosan and three analogues for FabI, the E. coli enoyl reductase.

Pharmacophore And Molecular Docking Guided 3d-Qsar Study Of Bacterial Enoyl-Acp Reductase (Fabi) Inhibitors

Identification of novel compounds against Acinetobacter baumannii 3-oxoacyl-[acyl-carrier-protein] synthase I (FabB) via comprehensive structure-based computational approaches

An integrated computational approach towards novel drugs discovery against polyketide synthase 13 thioesterase domain of Mycobacterium tuberculosis

IN-SILICO ADMET STUDY AND MOLECULAR DOCKING OF TRIAZOLE- 3-THIONE DERIVATIVES TARGETING LIPOTEICHOIC ACID SYNTHASE IN GRAM-POSITIVE BACTERIA

Computational Elucidation of the Binding Mechanisms of Curcumin Analogues As Bacterial RecA Inhibitors

Potential inhibitors of FemC to combat Staphylococcus aureus: virtual screening, molecular docking, dynamics simulation, and MM-PBSA analysis

Navigating the Chemical Space of ENR Inhibitors: A Comprehensive Analysis

Repurposing FDA-approved drugs for combating tigecycline resistance in Acinetobacter baumannii: in silico screening against BaeR protein

Design, Synthesis and Molecular Docking of 1,3,4-Oxadiazole-2(3H)-thione Derivatives Containing 1,4-Benzodioxane Skeleton as Potential FabH Inhibitors

In Silico Molecular Docking and Molecular Dynamics Analysis of Antimicrobial Triazole Derivatives: Insights from Synthesis, Computational and In Vitro Studies

Molecular Modeling Studies to Probe the Binding Hypothesis of Novel Lead Compounds against Multidrug Resistance Protein ABCB1

Integrated computer-aided drug design and biophysical simulation approaches to determine natural anti-bacterial compounds for Acinetobacter baumannii

Exploring the Possible Binding Mode of Trisubstituted Benzimidazoles Analogues in Silico for Novel Drug Designtargeting Mtb FtsZ

Exploring the Transmembrane Allostery in MexB: DB08385 Variant as Promising Inhibitor like Candidate Against Pseudomonas aeruginosa Antibiotic Resistance – A Computational Study

Rapid and Reliable Binding Affinity Prediction of Bromodomain Inhibitors: A Computational Study

Molecular docking-based virtual screening, drug-likeness, and pharmacokinetic profiling of some anti- Salmonella typhimurium cephalosporin derivatives

In silico analysis and characterization of potential inhibitors of MmaA3, a methoxy mycolic acid synthase from Mycobacterium tuberculosis

Exploration of potential hit compounds targeting 1-deoxy-d-xylulose 5-phosphate reductoisomerase (IspC) from Acinetobacter baumannii: an in silico investigation

Insights into bacterial interactions: Comparing fluorine-containing 1,2,4-triazoles to antibiotics using molecular docking and molecular dynamics approaches

Integrated virtual screening and MD simulation study to discover potential inhibitors of mycobacterial electron transfer flavoprotein oxidoreductase